# Doxycycline Treatment in Mild Thyroid-Associated Ophthalmopathy

> **NCT02203682** · PHASE2 · UNKNOWN · sponsor: **Sun Yat-sen University** · enrollment: 100 (estimated)

## Conditions studied

- Graves Ophthalmopathy
- Graves Disease
- Thyroid-associated Ophthalmopathy
- Thyroid Diseases
- Endocrine System Diseases
- Eye Diseases, Hereditary
- Hyperthyroidism
- Autoimmune Diseases
- Immune System Diseases

## Interventions

- **DRUG:** Doxycycline hyclate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02203682
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-07
- **Primary completion:** 2022-07
- **Final completion:** 2022-07
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2021-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02203682

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02203682, "Doxycycline Treatment in Mild Thyroid-Associated Ophthalmopathy". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02203682. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*